Resveratrol for Pain Due to Endometriosis

• Status: Completed
• Trial end date: 2015-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study aims to verify whether the use of 40 mg of resveratrol per day associated with monophasic contraceptive pill (levonorgestrel 0.15mg/ethinyl estradiol 0.03mg) reduces pelvic pain at the end of 2 months of treatment, compared to the use of the pill with placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Ethinyl Estradiol; Resveratrol

Criteria

Inclusion Criteria:

• Endometriosis diagnosed by laparoscopy

Exclusion Criteria:

• Known allergy to resveratrol

• Use of gonadotropin or danazol in the last month